PMW1: COSTS OF TREATMENT WITH DOXAZOSIN VERSUS TAMSULOSIN IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
D Thompson+3 more
openalex +1 more source
Single dose methodology to assess the influence of an α1‐adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia [PDF]
Sean Curtis+6 more
openalex +1 more source
Transurethral Balloon Laser Thermotherapy (TUBAL-T) for Symptomatic Benign Prostatic Hyperplasia
Yoshitsugu Nasu+3 more
openalex +2 more sources
A 50-year journey in the development of treatment for benign prostatic hyperplasia. [PDF]
Schally AV+4 more
europepmc +1 more source
Expression of CD 44 in human prostatic carcinoma and benign parostatic hyperplasia
祥華 張+4 more
openalex +2 more sources
Emphasis on the management of embedded capsular hyperplasia nodules associated with benign prostatic hyperplasia. [PDF]
Zheng C, Zhu Y, Jing Y, Xia S.
europepmc +1 more source
Correlation of Lower Urinary Tract Symptoms with Prostate Volume Parameters including Resistive Index and Presumed Circle Area Ratio in the Evaluation of Benign Prostatic Hyperplasia [PDF]
Myung-Soo Jeong, Jeong-Gu Lee
openalex +1 more source
Diagnosis and Treatment of Benign Prostatic Hyperplasia in Dogs: New Approaches. [PDF]
Derakhshandeh N, Mogheiseh A, Nazifi S.
europepmc +1 more source
Identification and Characterization of Differentially Expressed MicroRNAs in Benign Prostatic Hyperplasia. [PDF]
Song L, Wang X, Wang G, Zheng L, Zhou Z.
europepmc +1 more source